All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Instantino 0.25mg Injection
Prescription Required
Salt Composition : Palonosetron
Manufacturer : ZUVENTUS HEALTHCARE LTD
Origin of Medicine : India
1 Vial(s) Of 5ml
Introduction to Instantino 0.25mg Injection
Instantino 0.25mg injection is an antiemetic drug belonging to the class of 5-HT3Â receptor antagonists, containing the active ingredient Palonosetron. It is used to prevent and treat nausea, vomiting, or sickness caused by cancer treatments such as chemotherapy, radiotherapy, or after surgery. Nausea is characterised by stomach pain and the urge to vomit.
The common side effects that are likely to occur with this medicine are hives, swollen face, breathing trouble, and chest pain. Inform your healthcare provider if these side effects concern you or persist for longer than usual. It is given right away or later with anticancer medicines. It is usually given up to 24 hours while recovering from anesthesia after surgery.Â
Talk to your physician if you have a history of repeated constipation, blockage in the bowel, heart problems, or imbalance of certain minerals in your blood (such as magnesium and potassium). This medicine should not be used if you are allergic to this drug. Tell your physician about all the medications you have been taking recently, including herbal medicines and supplements, before taking the Instantino 0.25mg injection.
Uses of Instantino 0.25mg Injection
- Postoperative nausea and vomiting.
- Chemotherapy-induced nausea and vomiting.
Therapeutic Effects of Instantino 0.25mg Injection
It is a type of serotonin receptor antagonist, which works by blocking the action of serotonin in the body that induces nausea and vomiting. The chemotherapeutic trigger zone(CTZ) contains the receptor serotonin, when this CTZ is stimulated, vomiting occurs. This drug prevents the signals from serotonin and helps to reduce the symptoms of nausea and vomiting.
Interaction of Instantino 0.25mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Instantino 0.25mg injection and reduce effectiveness by causing undesirable side effects.Â
More Information about Instantino 0.25mg Injection
- Store Instantino 0.25mg injection in the original package at room temperature (25°C). Do not freeze.
- Keep it out of reach from children and pets.
- It is important to get the dose at the scheduled time. If you missed the schedule, contact your doctor and reschedule the dose.
How to consume Instantino 0.25mg Injection
The medicine will be administered to you by a healthcare professional in a hospital setting. Instantino 0.25mg injection is usually given about 30 minutes before you receive your anti-cancer medicine (chemotherapy) or right before anaesthesia for surgery.
Safety Advices for Instantino 0.25mg Injection
 Â
Pregnancy
 Â
It is unknown whether Instantino 0.25mg injection can be administered during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
 Â
Breast Feeding
 ÂIt is not known if Instantino 0.25mg injection passes into your breast milk or if it will affect your baby or your breast milk. Please consult your doctor before breastfeeding.Â
 Â
Lungs
  It is not known whether Instantino 0.25mg injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
 Â
Liver
  It is unknown whether Instantino 0.25mg injection can be administered to patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with this drug.Â
Â
 Â
Alcohol
 ÂIt is unknown whether consuming alcohol interacts with Instantino 0.25mg injection. Please consult your doctor for more advice.
 Â
Driving
 Â
It is unsafe to drive vehicles or operate heavy machinery after taking Instantino 0.25mg injection because it contains a small amount of alcohol which may cause dizziness and impair your concentration.
Side Effects of Instantino 0.25mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Hives
- Swollen face
- Breathing trouble
- Chest pain
Common
- Headache
- Fatigue
- Dizziness
- Abdominal pain.
Word of Advice
Talk to your physician if you have a history of repeated constipation, blockage in the bowel, heart problems, or imbalance of certain minerals (such as potassium and magnesium) in your blood before taking Instantino 0.25mg injection. Inform your doctor or nurse if you are taking any medicines that affect your heartbeat because they could cause a heartbeat problem when taken with this injection.
FAQs
Q 1. What are the possible side effects of Instantino 0.25mg injection?
It can cause serious allergic reactions like hives, swollen face, breathing trouble, and chest pain. Some common side effects include headache and constipation.
Q 2. When should you take the Instantino 0.25mg injection?
The first dose of this drug is typically taken before the start of your surgery, chemotherapy, or radiation treatment.
Q 3. How does an Instantino 0.25mg injection work?
Instantino 0.25mg injection works by blocking the action of a chemical called serotonin, which is involved in causing nausea and vomiting.
Q 4. Who should not take an Instantino 0.25mg injection?
Instantino 0.25mg injection should not be taken by individuals who are allergic to it or its ingredients.
Q 5. What forms does the Instantino 0.25mg injection come in?
Instantino 0.25mg injection is available in the injection form.
Fact Box of Instantino 0.25mg Injection
Molecule name: Palonosetron | Therapeutic class: Antiemetics |
Pharmacological class: 5-HT3 receptor antagonists | Indications:Â 1.Postoperative nausea and vomiting. 2.Chemotherapy induced nausea and vomiting. |
References
- Helsinn Birex Pharmaceuticals Ltd, Electronic medicines compendium (EMC), [Revised on Dec 2021] [ Accessed on 01st March 2023], https://www.medicines.org.uk/emc/files/pil.513.pdf
- Fresenius Kabi, US Food and Drug Administration, [Revised on Dec 2018] [Accessed on 01st March 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208109s001lbl.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Treatment of disorders of bowel motility and water flux, 12th edition, 2011, 1341.
- KD Tripathi, Essentials of Medical Pharmacology, Antiemetic, prokinetic and digestant drugs, 7th edition, 2013, 669.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
